y 27632 has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Seto, M | 1 |
| Araie, M; Honjo, M; Kameda, T; Kawaji, T; Tanihara, H; Yoshimura, N | 1 |
1 review(s) available for y 27632 and Glaucoma
| Article | Year |
|---|---|
[Rho-kinase inhibitors].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Clinical Trials as Topic; Coronary Artery Disease; Drug Design; Glaucoma; Humans; Hypertension, Pulmonary; Mice; Molecular Targeted Therapy; Pyridines; Rats; rho-Associated Kinases; Vasospasm, Intracranial | 2011 |
1 other study(ies) available for y 27632 and Glaucoma
| Article | Year |
|---|---|
Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Topics: Actins; Amides; Animals; Cell Adhesion; Cell Differentiation; Cell Movement; Cell Proliferation; Cicatrix; Collagen Type I; Connective Tissue Cells; Cytoskeletal Proteins; Enzyme Inhibitors; Female; Fibroblasts; Fibronectins; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Postoperative Complications; Pyridines; Rabbits; rho-Associated Kinases; Sclerostomy; Wound Healing | 2007 |